Product
Delpazolid
Aliases
LCB01-0371, Placebo of Delpazolid, Placebo of LCB01-0371
3 clinical trials
5 indications
Indication
Infections and InfestationsIndication
TuberculosisIndication
Nontuberculous Mycobacteria InfectionIndication
Mycobacterium abscessus infectionClinical trial
A Multicenter, Double-blinded, Randomized, Parallel Design, Phase IIa Clinical Trial to Evaluate the Efficacy, Safety and PK of LCB01-0371 With Vancomycin Versus Vancomycin Monotherapy in Patients With MRSA BacteremiaStatus: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
A Phase IIb, Open Label, Randomized Controlled Dose Ranging Multi-Center Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Exposure-Response Relationship of Different Doses of Delpazolid in Combination With Bedaquiline Delamanid Moxifloxacin in Adult Subjects With Newly Diagnosed, Uncomplicated, Smear-Positive, Drug-sensitive Pulmonary TuberculosisStatus: Completed, Estimated PCD: 2023-01-04
Clinical trial
A Phase 2a, Open-label, Single-arm, Multi-center Study to Evaluate the Efficacy and Safety of LCB01-0371 (Delpazolid) as Add-on Therapy in Patients With Refractory Mycobacterium Abscessus Complex Pulmonary DiseaseStatus: Active (not recruiting), Estimated PCD: 2025-07-29